光红梅(邀请中)主任药师/国家药品监督管理局药品审评中心

◈ 09:20-09:55Updates on the Status of Disease-targeting Molecular Imaging and Therapy by the Chinese Scientists 程震教授中国科学院上海药物研究所

分子影像中心主任

◈ 09:55-10:10茶歇交流◈ 10:10-10:45The Shared Perspectives of New Radiopharmaceuticals: The Alignment of Investors with Developers《投资者与开发者对放射性新药的共同期待》唐艳旻(Amy Tang)启明创投投资合伙人

北京先通CEO

◈ 10:45-11:20Grand Pharma Entering Radiopharmaceuticals: Answering Current Challenges for Future Perspectives史琳博士远大医药 (中国) 有限公司副总裁/首席医学官

◈ 11:20-11:55The Efforts and Actions from Nation-owned Enterprise as the Industrial leader to Promote the Radiopharmaceutical Development and Commercialization in China杜进博士中国同位素与辐射公司总工程师

原子高科董事长

◈ 11:55-13:30午餐休息◈ 13:30-14:05Translational Research for Novel Radiopharmaceuticals in Indicated Patients under Investigator-Sponsored Study (ISS) Mechanism in Qualified Institutional Hospitals—PUMCH Experience 霍力教授北京协和医院核医学科主任

主任医师

◈ 14:05-14:40Radiolabeled Drug vs Imaging Agent, The Pre-clinical and Translational Studies


光红梅 可能工作过的组织/机构/部门/团队:


光红梅 可能工作过的同事:

粤ICP备17091748号-1
剧本杀复盘 剧本杀复盘 红酒 ChatGPT
澳超联赛直播